Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Susu Xiao'er Zhike Granules for Children's Cold-Induced Cough
NCT06773117Phase 3Not yet recruiting
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Sep 2025
- Primary completion
- May 2027
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 3 trial of Susu Xiao'er Zhike Granules in cough, common cold, sponsored by Tasly Pharmaceutical Group Co., Ltd.. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
Susu Xiao'er Zhike Granules
03
Conditions
coughcommon cold
Beyond the preview
Go deeper on NCT06773117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06773117.